These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15878878)

  • 1. Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.
    Xu XM; Zhou YQ; Wang MH
    J Biol Chem; 2005 Jul; 280(26):25087-94. PubMed ID: 15878878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
    Wang MH; Lao WF; Wang D; Luo YL; Yao HP
    Cancer Biol Ther; 2007 Jul; 6(7):1121-9. PubMed ID: 17611409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
    Danilkovitch-Miagkova A; Miagkov A; Skeel A; Nakaigawa N; Zbar B; Leonard EJ
    Mol Cell Biol; 2001 Sep; 21(17):5857-68. PubMed ID: 11486025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
    Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW
    J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
    Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
    Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase.
    Yao HP; Luo YL; Feng L; Cheng LF; Lu Y; Li W; Wang MH
    Cancer Biol Ther; 2006 Sep; 5(9):1179-86. PubMed ID: 16880737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
    Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C
    Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental expression of Wnt signaling factors in mouse brain.
    Coyle-Rink J; Del Valle L; Sweet T; Khalili K; Amini S
    Cancer Biol Ther; 2002; 1(6):640-5. PubMed ID: 12642687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
    Morrison JA; Klingelhutz AJ; Raab-Traub N
    J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
    Lee YK; Lin TH; Chang CF; Lo YL
    PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell proliferation through TGF-β receptor II (TGFRII)-Akt-β-catenin signaling.
    Cheng L; Zhang C; Li D; Zou J; Wang J
    Int J Mol Sci; 2014 Jul; 15(7):12665-76. PubMed ID: 25036031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
    Dar AA; Belkhiri A; El-Rifai W
    Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.